These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 18164316)

  • 1. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
    Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
    Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
    Yamaguchi N; Yamaguchi N
    FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the A20 OTU domain and mechanistic insights into deubiquitination.
    Komander D; Barford D
    Biochem J; 2008 Jan; 409(1):77-85. PubMed ID: 17961127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.
    Evans PC; Ovaa H; Hamon M; Kilshaw PJ; Hamm S; Bauer S; Ploegh HL; Smith TS
    Biochem J; 2004 Mar; 378(Pt 3):727-34. PubMed ID: 14748687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
    Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
    J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling.
    Bosanac I; Wertz IE; Pan B; Yu C; Kusam S; Lam C; Phu L; Phung Q; Maurer B; Arnott D; Kirkpatrick DS; Dixit VM; Hymowitz SG
    Mol Cell; 2010 Nov; 40(4):548-57. PubMed ID: 21095585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of the A20/ABIN-mediated inhibition of NF-κB signaling via modifying the ubiquitinated proteins in a basal chordate.
    Yuan S; Dong X; Tao X; Xu L; Ruan J; Peng J; Xu A
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6720-5. PubMed ID: 24753567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
    Verstrepen L; Carpentier I; Verhelst K; Beyaert R
    Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trim13 Potentiates Toll-Like Receptor 2-Mediated Nuclear Factor
    Huang B; Baek SH
    Mol Pharmacol; 2017 Apr; 91(4):307-316. PubMed ID: 28087809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
    Shembade N; Ma A; Harhaj EW
    Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating dynamic protein-protein interactions and ubiquitination in NF-κB signaling pathways.
    Shembade N; Harhaj EW
    Methods Mol Biol; 2015; 1280():283-95. PubMed ID: 25736755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain.
    Bohgaki M; Tsukiyama T; Nakajima A; Maruyama S; Watanabe M; Koike T; Hatakeyama S
    Biochim Biophys Acta; 2008 May; 1783(5):826-37. PubMed ID: 18029035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal ubiquitin-associated domain of Cezanne is crucial for its function to suppress NF-κB pathway.
    Ji Y; Cao L; Zeng L; Zhang Z; Xiao Q; Guan P; Chen S; Chen Y; Wang M; Guo D
    J Cell Biochem; 2018 Feb; 119(2):1979-1991. PubMed ID: 28817177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
    Ning S; Pagano JS
    J Virol; 2010 Jun; 84(12):6130-8. PubMed ID: 20392859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
    Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
    EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
    Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
    J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.